Century Therapeutics, Inc. (IPSC) Financials

IPSC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 287.0 million 54.7 million
March 31, 2026 326.6 million 61.8 million
Dec. 31, 2025 223.7 million 64.8 million
Sept. 30, 2025 244.7 million 68.4 million

IPSC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -20.5 million 2.0 million
March 31, 2026 -25.8 million 1.4 million
Dec. 31, 2025 -16.4 million 1.3 million
Sept. 30, 2025 -25.8 million 892000

IPSC Net Income

No data available :(

IPSC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 119.7 million - 34.6 million
March 31, 2026 134.8 million 43.9 million 4.1 million
Dec. 31, 2025 117.1 million - 43.6 million
Sept. 30, 2025 132.7 million - 41.2 million

IPSC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 205.8 million
March 31, 2026 86.6 million
Dec. 31, 2025 86.6 million
Sept. 30, 2025 86.5 million

IPSC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 694000 19.6 million 5.8 million -
March 31, 2026 584000 14.1 million 6.6 million -
Dec. 31, 2025 317000 19.7 million 956000 -
Sept. 30, 2025 195000 22.5 million 6.8 million -

IPSC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 3.0 million
Dec. 31, 2025 - 3.6 million
Sept. 30, 2025 - 22.5 million

IPSC

Price: $1.37

52 week price:
0.44
3.04

Earnings Per Share: -1.00 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 69234

Market Capitalization: 271.6 million

Links: